MedTrace Logo

Effectiveness & Safety of Neofitoroid® in Hemorrhoidal Disease

NCT03545724 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2019-05-30

No results posted yet for this study

Summary

Evaluation of the effect and safety of NeoFitoroid® in reducing symptoms in patients with hemorrhoidal disease.

Conditions

Interventions

DEVICE

Neofitoroid®

NeoFitoroid® forms a protective barrier mucosa and on perianal region that can aid the physiological process of healing.

Sponsors & Collaborators

  • GB Pharma Group

    collaborator UNKNOWN

  • Aboca Spa Societa' Agricola

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-07
Primary Completion
2018-11-19
Completion
2019-05-16

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03545724 on ClinicalTrials.gov